← Back to TECH

BIO TECHNE CORP financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSSep 2026Filed 12/11/2026Mar 2026Filed 06/05/2026Dec 2025Filed 04/02/2026Sep 2025Filed 12/11/2026Mar 2025Filed 06/05/2026Dec 2024Filed 04/02/2026Sep 2024Filed 05/11/2025Mar 2024Filed 08/05/2025
$300$311$296$287$316$297$289$303
$28$51$38$38$23$35$34$49
$0.18$0.32$0.24$0.24$0.14$0.22$0.21$0.31
158157157156159161161160

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.